AP MOELLER-MAERSK AS A financial statements, including revenue, expenses, profit, and loss

The total revenue of MRSA for the last quarter is 14.35 B EUR, and it's 21.19% higher compared to the previous quarter. The net income of Q3 24 is 2.78 B EUR.